Literature DB >> 22930205

Catastrophic antiphospholipid syndrome triggered by fulminant disseminated herpes simplex infection in a patient with systemic lupus erythematosus.

C Catoggio1, A Alvarez-Uría, P L Fernandez, R Cervera, G Espinosa.   

Abstract

Infections are considered one of the most common causes of morbidity and mortality in patients with systemic lupus erythematosus (SLE), and occasionally can trigger a catastrophic antiphospholipid syndrome (APS). We describe a 22-year-old SLE patient with lupus nephritis under immunosuppressant therapy and asymptomatic carrier of antiphospholipid antibodies, who was admitted with tonsillitis and acute hepatitis, developing multiorgan failure in a few hours. Postmortem examination revealed hepatic necrosis, tonsillitis, pharyngitis and uterine cervicitis caused by herpes simplex virus (HSV) together with microthrombosis in lungs and glomerular arterioles, suggesting the diagnosis of fulminant HSV disseminated infection and catastrophic APS.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22930205     DOI: 10.1177/0961203312458841

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  4 in total

Review 1.  Entangling COVID-19 associated thrombosis into a secondary antiphospholipid antibody syndrome: Diagnostic and therapeutic perspectives (Review).

Authors:  Eugenio Cavalli; Alessia Bramanti; Rosella Ciurleo; Andrey I Tchorbanov; Antonio Giordano; Paolo Fagone; Cristina Belizna; Placido Bramanti; Yehuda Shoenfeld; Ferdinando Nicoletti
Journal:  Int J Mol Med       Date:  2020-06-25       Impact factor: 4.101

2.  Prothrombotic autoantibodies in serum from patients hospitalized with COVID-19.

Authors:  Yu Zuo; Shanea K Estes; Ramadan A Ali; Alex A Gandhi; Srilakshmi Yalavarthi; Hui Shi; Gautam Sule; Kelsey Gockman; Jacqueline A Madison; Melanie Zuo; Vinita Yadav; Jintao Wang; Wrenn Woodard; Sean P Lezak; Njira L Lugogo; Stephanie A Smith; James H Morrissey; Yogendra Kanthi; Jason S Knight
Journal:  Sci Transl Med       Date:  2020-11-02       Impact factor: 17.956

3.  Can hydroxychloroquine be protective against COVID-19-associated thrombotic events ?

Authors:  Christian A Devaux; Laurence Camoin-Jau; Jean-Louis Mege; Didier Raoult
Journal:  J Microbiol Immunol Infect       Date:  2021-01-05       Impact factor: 4.399

Review 4.  Dorsolateral medullary infarction during skin infection by Stenotrophomonas maltophilia in a patient with triple antiphospholipid antibody positivity: a case-based review.

Authors:  Yu-Lan Chen; Hai-Tao Yang; Li-Xiong Liu; Cui-Hong Chen; Qin Huang; Xiao-Ping Hong; Jiu-Liang Zhao; Dong-Zhou Liu
Journal:  Clin Rheumatol       Date:  2020-11-05       Impact factor: 2.980

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.